INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
03/15/2026
Back to search
Official data from USPTO
NOBELPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
03/16/2026
Trademark type
Combined
Nice classes
5
Filing date
09/13/2019
Registration date
03/24/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/15/2025
Last transaction
03/16/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
Tokyo, JP
Examiner
ORTIGA PALMER, RAMONA
Current location
Historical data usage
Holders and representatives
Holders
Nobelpharma Co., Ltd.
Nobelpharma Co., Ltd.
Representatives
Sandra Epp Ryan HSML P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for treating tympanic membrane perforation and ear canal soft tissue defect; pharmaceutical preparations for treating skin disorders ; vaccines; vaccines for treating malaria; pharmaceutical preparations for dysmenorrhea; pharmaceutical preparations for hypozincemia; pharmaceutical preparations for tympanic perforation; pharmaceutical preparations for sleep disorders; pharmaceutical preparations for pulmonary alveolar proteinosis; pharmaceutical preparations for distal myopathy; pharmaceutical preparations for CMV infection; pharmaceutical preparations for lymphatic disorder; pharmaceutical preparations for fibrodysplasia ossificans progressive; pharmaceutical preparations for Pendred syndrome
Publications
History of USPTO decisions and trademark events.
27 publications found
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
07/15/2025
71AG
REGISTERED-SEC.71 ACCEPTED
07/15/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/15/2025
ES71
TEAS SECTION 71 RECEIVED
04/17/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/24/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/07/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/24/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/23/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/23/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/23/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/23/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/23/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/23/2021
GPNX
NOTIFICATION PROCESSED BY IB
05/22/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/07/2020
FIMP
FINAL DISPOSITION PROCESSED
05/07/2020
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
04/23/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
03/24/2020
PUBO
PUBLISHED FOR OPPOSITION
01/07/2020
NPUB
NOTICE OF PUBLICATION
12/18/2019
MAFR
APPLICATION FILING RECEIPT MAILED
12/07/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/04/2019
DOCK
ASSIGNED TO EXAMINER
12/03/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/03/2019
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
12/02/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/28/2019
Continuous trademark protection
Get notified about every new filing that threatens NOBELPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.